Therefore, where evidence is available, a distinction is made in the chapters listed between BRCA1/2-pV carriers and carriers of pV in another breast and/or ovarian cancer risk gene and those with pV in the Lynch genes. This evidence concerns the gene BRCA1 and ovarian carcinoma.